Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/16/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 95.8k | $10.45 | $1M | | 05/13/2022 |
05/13/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 35.8k | $10.45 | $374.5k | | 05/13/2022 |
05/12/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 124.5k | $10.39 | $1.3M | | 05/10/2022 |
05/11/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 17.7k | $10.38 | $183.6k | | 05/10/2022 |
05/10/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 18.7k | $10.38 | $193.9k | | 05/10/2022 |
05/09/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 17.6k | $10.37 | $182.6k | | 05/05/2022 |
05/06/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 48.3k | $10.37 | $501.2k | | 05/05/2022 |
05/05/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 20.7k | $10.37 | $215.1k | | 05/05/2022 |
05/04/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 37.5k | $10.37 | $388.9k | | 05/02/2022 |
05/03/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 79.5k | $10.37 | $824.4k | | 05/02/2022 |
05/02/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 153.7k | $10.38 | $1.6M | | 05/02/2022 |
04/29/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 69.2k | $10.38 | $718.7k | | 04/27/2022 |
04/28/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 73.4k | $10.38 | $761.9k | | 04/27/2022 |
04/27/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 47.4k | $10.38 | $492k | | 04/27/2022 |
04/26/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 64.7k | $10.38 | $671.6k | | 04/22/2022 |
04/25/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 27.7k | $10.39 | $287.4k | | 04/22/2022 |
04/22/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 37.4k | $10.39 | $388.8k | | 04/22/2022 |
04/21/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 62.2k | $10.38 | $645.9k | | 04/19/2022 |
04/20/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 85.6k | $10.39 | $889.4k | | 04/19/2022 |
04/19/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Sale | Common Stock | 399.9k | $10.42 | $4.2M | | 04/19/2022 |
04/22/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (acquisition) | 5% Convertible Note due 2021 | 0 | $0.00 | $0 | | 04/22/2021 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Common Stock | 3.5M | $0.00 | $0 | | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Purchase | Common Stock | 200k | $15.00 | $3M | | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series A Preferred Stock | 12.5M | $0.00 | $0 | | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series B Preferred Stock | 8.8M | $0.00 | $0 | | 08/11/2020 |
08/11/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Conversion | Series C Preferred Stock | 3.6M | $0.00 | $0 | | 08/11/2020 |
07/06/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 4.6k | $33.83 | $155.7k | See footnote | 07/01/2020 |
07/02/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.8k | $33.63 | $127.8k | See footnote | 07/01/2020 |
07/01/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 108.1k | $34.45 | $3.7M | See footnote | 07/01/2020 |
03/06/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.8k | $23.79 | $42.8k | See footnote | 03/04/2020 |
03/05/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 8.5k | $23.53 | $200k | See footnote | 03/04/2020 |
03/04/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 35.6k | $23.81 | $848.8k | See footnote | 03/04/2020 |
03/03/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 6.4k | $23.00 | $147.2k | See footnote | 02/28/2020 |
03/02/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 10.3k | $23.06 | $237.5k | See footnote | 02/28/2020 |
02/28/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 5.1k | $21.30 | $108.7k | See footnote | 02/28/2020 |
|